NCT03725956

Brief Summary

Nasal polyposis (NP) is a chronic inflammatory disease of the nasal and sinus mucosa leading to protrusion of edematous polyps in the nasal cavity. Prevalence of NP among the chronic rhinosinusitis patients is 25-30 %. NP leads to significant limitations in physical, emotional and social aspects of life of the affected patients. Sleep disorder is frequently reported by those patients with impaired nasal breathing. Till now few studies have objectively assessed the impact of NP on sleep quality. the objectives are to figure out sleep disturbances in NP and to analyze the outcomes of sinus surgery on sleep recovering.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jan 2019Dec 2026

First Submitted

Initial submission to the registry

October 18, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 31, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

January 17, 2019

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

6.9 years

First QC Date

October 18, 2018

Last Update Submit

April 29, 2026

Conditions

Keywords

Nasal polyposissleepsinus surgerypolysomnographyquality of life

Outcome Measures

Primary Outcomes (1)

  • Change in Slow-wave sleep duration

    Slow-wave sleep duration is measured one month before surgery and 3 months after surgery

    1 month before surgery and 3 months postoperatively

Secondary Outcomes (5)

  • change in total sleep duration

    At 1 month before surgery and at 3 months postoperatively

  • Change in the number of brief wakefulness

    At 1 month before surgery and at 3 months postoperatively

  • change in Apnea-hypopnea index

    At 1 month before surgery and at 3 months postoperatively

  • Change in time with oxygen desaturation below 90%

    At 1 month before surgery and at 3 months postoperatively

  • change in Epworth sleepiness scale scores

    At 1 month before surgery and at 3 months postoperatively

Study Arms (1)

endoscopic sinus surgery

EXPERIMENTAL

Single group of patients with nasal polyposis eligible for endoscopic sinus surgery

Procedure: Endoscopic sinus surgery

Interventions

Surgical procedure under general anaesthesia: Consists of the removal of bone boundaries between sinus cavities (ethmoidectomy) with nasal polyps resection in order to retrieve nasal patency and sinus drainage Polysomnographic assessment as routinely applied in clinical practice

endoscopic sinus surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent endoscopic sinus surgery for recalcitrant nasal polyposis (failure of a 4-month corticosteroid medical treatment) Social insured patient
  • Patient willing to comply with all procedures of the study and its duration
  • Patient giving consent

You may not qualify if:

  • Patients with previous nasal surgery for nasal polyposis
  • Patients with previous continuous positive airway pressure therapy for obstructive sleep apnea
  • Non-coverage by the social security scheme
  • Patient unable to receive informed information
  • Refusal to sign the consent
  • Person deprived of the liberty
  • Person benefiting from a system of legal protection (guardianship…)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Claude Huriez, CHU

Lille, France

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveNasal Polyps

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesNose DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Geoffrey Mortuaire, MD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2018

First Posted

October 31, 2018

Study Start

January 17, 2019

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations